One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1016/j.annonc.2023.04.022
Copy DOI Journal: Annals of Oncology |  Publication Date: Jun 1, 2023 |
 Citations: 2 |
Affiliation: Baylor University Medical Center, Harvard University, Dana-Farber Cancer Institute, Hôpital Claude Huriez, University of Lille, The University of Texas MD Anderson Cancer Center, Duke Institute for Health Innovation, Bristol-Myers Squibb (United States), Akita University Hospital, Princess Margaret Cancer Centre, John Paul II Hospital, Jagiellonian University, University Hospital Cologne, University of Cologne, Johannes Gutenberg University Mainz, Sidney Kimmel Comprehensive Cancer Center, Ghent University Hospital, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, KU LeuvenO-7 Adjuvant nivolumab vs placebo in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: First report of comprehensive biomarker analyses from CheckMate 577
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
